Recorded August 26, 2023. This transcript has been edited for clarity.
Robert A. Harrington, MD: Hi. This is Bob Harrington from Weill Cornell Medicine. It's my first show while at Weill Cornell Medicine. I'm here with my good friend, Manesh Patel, from Duke University. We're at the European Society of Cardiology (ESC) congress in Amsterdam, and I pulled Manesh into the studio for a conversation about something that's really topical right now: sudden cardiac death in athletes.
What I hope to do over the course of the next 15 minutes or so is really pick Manesh's brain on how we are thinking about this. Are we going to think about treatment issues? Are we going to think about prevention issues? Are we thinking about screening? We'll try to make it practical.
Dr Manesh Patel is chief of cardiovascular medicine at Duke University and also the director of the Duke Heart Center. Manesh, thanks for joining me here.
Bronny James and Damar Hamlin
Manesh R. Patel, MD: Excited to be here, Bob. Always.
Harrington: You and I talked about this topic a few weeks ago, and then just yesterday a news article comes out about the cause of Bronny James' sudden cardiac arrestLet me put this into a bigger societal context.
Sadly, ARTESIA Doesn't Answer a Common Question in Cardiology
Pediatric Ventricular Tachycardia
COMMENTARY
SCD in Athletes: Lessons From High-Profile Cases
Robert A. Harrington, MD; Manesh R. Patel, MD
DisclosuresSeptember 18, 2023
Recorded August 26, 2023. This transcript has been edited for clarity.
Robert A. Harrington, MD: Hi. This is Bob Harrington from Weill Cornell Medicine. It's my first show while at Weill Cornell Medicine. I'm here with my good friend, Manesh Patel, from Duke University. We're at the European Society of Cardiology (ESC) congress in Amsterdam, and I pulled Manesh into the studio for a conversation about something that's really topical right now: sudden cardiac death in athletes.
What I hope to do over the course of the next 15 minutes or so is really pick Manesh's brain on how we are thinking about this. Are we going to think about treatment issues? Are we going to think about prevention issues? Are we thinking about screening? We'll try to make it practical.
Dr Manesh Patel is chief of cardiovascular medicine at Duke University and also the director of the Duke Heart Center. Manesh, thanks for joining me here.
Bronny James and Damar Hamlin
Manesh R. Patel, MD: Excited to be here, Bob. Always.
Harrington: You and I talked about this topic a few weeks ago, and then just yesterday a news article comes out about the cause of Bronny James' sudden cardiac arrestLet me put this into a bigger societal context.
Credits:
Lead image: Michael Hickey/Getty Images
© 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: SCD in Athletes: Lessons From High-Profile Cases - Medscape - Sep 18, 2023.
Tables
Authors and Disclosures
Authors and Disclosures
Authors
Robert A. Harrington, MD
Stephen and Suzanne Weiss Dean, Weill Cornell Medicine; Provost for Medical Affairs, Cornell University, New York, NY
Disclosure: Robert A. Harrington, MD, has disclosed the following relevant financial relationships:
Research relationships with: Baim Institute (DSMB); CSL (RCT executive committee); Janssen (RCT chair); National Heart, Lung, and Blood Institute (RCT executive committee, DSMB chair); Patient-Centered Outcomes Research Institute (RCT co-chair); Duke Clinical Research Institute
Consulting relationships with: Atropos Health; Bitterroot Bio; Bristol Myers Squibb; BridgeBio; Element Science; Edwards Lifesciences; Foresite Labs; Medscape/WebMD Board of Directors for: American Heart Association; College of the Holy Cross; Cytokinetics
Manesh R. Patel, MD
Professor of Medicine, Duke University; Chief, Division of Cardiology; Director, Duke Heart Center, Duke University Medical Center, Durham, North Carolina
Disclosure: Manesh R. Patel, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Bayer; Janssen; Novartis (consultant)
Received research grant from: Bayer; Janssen